Commonwealth Coat of Arms of Australia
 

 

PB 104 of 2024

 

National Health (Originator Brand) Amendment Determination 2024 (No. 3)

 I, Nikolai Tsyganov, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination.

Dated   26 September  2024  

NIKOLAI TSYGANOV

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health and Aged Care


Contents

1  Name

2  Commencement

3  Authority

4  Schedules

Schedule 1—Amendments

National Health (Originator Brand) Determination 2015 (PB 100 of 2015)

 

 

1  Name

  This instrument is the National Health (Originator Brand) Amendment Determination 2024 (No. 3).

  This instrument may also be cited as PB 104 of 2024.

2  Commencement

 (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

 1 October 2024

 

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3  Authority

  This instrument is made under subsection 99ADB(6B) of the National Health Act 1953.

4  Schedules

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Originator Brand) Determination 2015 (PB 100 of 2015)

1  Schedule 1, (after table item 204A)

 

Repeal:

 

204B

Rivastigmine

 

 

 

 

Exelon

Oral

 

Exelon Patch 5

Exelon Patch 10

Exelon Patch 15

Transdermal

 

204C

Rizatriptan

Maxalt

 

 

 

Substitute:

 

204B

Rivaroxaban

Xarelto

Oral

 

204C

Rivastigmine

 

 

 

 

Exelon

Oral

 

Exelon Patch 5

Exelon Patch 10

Exelon Patch 15

Transdermal

 

204D

Rizatriptan

Maxalt